![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Otsuka Holdings Co Limited (PK) | USOTC:OTSKY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.11 | 0.52% | 21.16 | 21.13 | 21.69 | 21.72 | 20.40 | 20.40 | 44,489 | 21:00:03 |
Japanese drug maker Otsuka Pharmaceutical Co. has agreed to buy California-based Avanir Pharmaceuticals Inc. in a deal that values the Nasdaq-traded company at $3.5 billion.
Avanir said in a statement Tuesday that Otsuka Pharmaceutical will buy the company for $17 a share in cash, noting that the boards of directors of both companies have approved the transaction.
Avanir develops drugs to treat central nervous system disorders. The companies said that Avanir would partner with Otsuka in the U.S. to continue development of the drugs and on their commercialization efforts.
The companies expect the deal to close in the first quarter of 2015, with Avanir becoming an independent unit of Otsuka's U.S. operations.
Access Investor Kit for Otsuka Holdings Co., Ltd.
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=JP3188220002
Access Investor Kit for Avanir Pharmaceuticals, Inc.
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US05348P4019
Access Investor Kit for Otsuka Holdings Co., Ltd.
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US6891641010
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Otsuka (PK) Chart |
1 Month Otsuka (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions